A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF RO7247669 COMBINED WITH NAB-PACLITAXEL COMPARED WITH PEMBROLIZUMAB COMBINED WITH NAB-PACLITAXEL IN PARTICIPANTS WITH PREVIOUSLY UNTREATED, PD-POSITIVE, LOCALLY-ADVANCED UNRESECTABLE OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

CTRC Inpatient
Lone Tree Medical Center
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Jennifer Diamond

Jennifer Diamond

Study ID

Protocol Number: 23-1623

More information available at ClinicalTrials.gov: NCT05852691

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers